|
1
|
Bentham J and Bhattacharya S: Genetic
mechanisms controlling cardiovascular development. Ann NY Acad Sci.
1123:10–19. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Molkentin JD, Lin Q, Duncan SA and Olson
EN: Requirement of the transcription factor GATA4 for heart tube
formation and ventral morphogenesis. Genes Dev. 11:1061–1072. 1997.
View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Brunskill EW, Witte DP, Yutzey KE and
Potter SS: Novel cell lines promote the discovery of genes involved
in early heart development. Dev Biol. 235:507–520. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Temsah R and Nemer M: GATA factors and
transcriptional regulation of cardiac natriuretic peptide genes.
Regul Pept. 128:177–185. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Sarkozy A, Conti E, Neri C, D’Agostino R,
Digilio MC, Esposito G, Toscano A, Marino B, Pizzuti A and
Dallapiccola B: Spectrum of atrial septal defects associated with
mutations of NKX2.5 and GATA4 transcription factors. J Med Genet.
42:e162005. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Garg V, Kathiriya IS, Barnes R, et al:
GATA4 mutations cause human congenital heart defects and reveal an
interaction with TBX5. Nature. 424:443–447. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Christoforou N, Chellappan M, Adler AF,
Kirkton RD, Wu T, Addis RC, Bursac N and Leong KW: Transcription
factors MYOCD, SRF, Mesp1 and SMARCD3 enhance the cardio-inducing
effect of GATA4, TBX5, and MEF2C during direct cellular
reprogramming. PLoS One. 8:e635772013. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Dodou E, Verzi MP, Anderson JP, Xu SM and
Black BL: Mef2c is a direct transcriptional target of ISL1 and GATA
factors in the anterior heart field during mouse embryonic
development. Development. 131:3931–3942. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Chen Y, Han ZQ, Yan WD, Tang CZ, Xie JY,
Chen H and Hu DY: A novel mutation in GATA4 gene associated with
dominant inherited familial atrial septal defect. J Thorac
Cardiovasc Surg. 140:684–687. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Xiang R, Fan LL, Huang H, Cao BB, Li XP,
Peng DQ and Xia K: A novel mutation of GATA4 (K319E) is responsible
for familial atrial septal defect and pulmonary valve stenosis.
Gene. 534:320–323. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Garg V, Kathiriya IS, Barnes R,
Schluterman MK, King IN, Butler CA, Rothrock CR, Eapen RS,
Hirayama-Yamada K, Joo K, Matsuoka R, Cohen JC and Srivastava D:
GATA4 mutations cause human congenital heart defects and reveal an
interaction with TBX5. Nature. 424:443–447. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Maitra M, Schluterman MK, Nichols HA,
Richardson JA, Lo CW, Srivastava D and Garg V: Interaction of Gata4
and Gata6 with Tbx5 is critical for normal cardiac development. Dev
Biol. 326:368–377. 2009. View Article : Google Scholar :
|
|
13
|
Laforest B and Nemer M: GATA5 interacts
with GATA4 and GATA6 in outflow tract development. Dev Biol.
358:368–378. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Rajagopal SK, Ma Q, Obler D, et al:
Spectrum of heart disease associated with murine and human GATA4
mutation. J Mol Cell Cardiol. 43:677–685. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Misra C, Sachan N, McNally CR, Koenig SN,
Nichols HA, Guggilam A, Lucchesi PA, Pu WT, Srivastava D and Garg
V: Congenital heart disease-causing Gata4 mutation displays
functional deficits in vivo. PLoS Genet. 8:e10026902012. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Tang Y, Han Z, Han H and Chen Y: Mechanism
involved in the familial atrial septal defects caused by GATA-4
M310V single gene mutation. China Circ J. 3:211–214. 2013.In
Chinese.
|
|
17
|
Ballester M, Castelló A, Ibáñez E, Sánchez
A and Folch JM: Real-time quantitative PCR-based system for
determining transgene copy number in transgenic animals.
Biotechniques. 37:610–613. 2004.PubMed/NCBI
|
|
18
|
Nemer G, Fadlalah F, Usta J, Nemer M,
Dbaibo G, Obeid M and Bitar F: A novel mutation in the GATA4 gene
in patients with Tetralogy of Fallot. Hum Mutat. 27:293–294. 2006.
View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Zeisberg EM, Ma Q, Juraszek AL, Moses K,
Schwartz RJ, Izumo S and Pu WT: Morphogenesis of the right
ventricle requires myocardial expression of Gata4. J Clin Invest.
115:1522–1531. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Pu WT, Ishiwata T, Juraszek AL, Ma Q and
Izumo S: GATA4 is a dosage-sensitive regulator of cardiac
morphogenesis. Dev Biol. 275:235–244. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
McBride K and Nemer M: Regulation of the
ANF and BNP promoters by GATA factors: Lessons learned for cardiac
transcription. Can J Physiol Pharmacol. 79:673–681. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Molkentin JD, Kalvakolanu DV and Markham
BE: Transcription factor GATA-4 regulates cardiac muscle-specific
expression of the alpha-myosin heavy-chain gene. Mol Cell Biol.
14:4947–4957. 1994.PubMed/NCBI
|
|
23
|
Morin S, Charron F, Robitaille L and Nemer
M: GATA-dependent recruitment of MEF2 proteins to target promoters.
EMBO J. 19:2046–2055. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Ip HS, Wilson DB, Heikinheimo M, Tang Z,
Ting CN, Simon MC, Leiden JM and Parmacek MS: The GATA-4
transcription factor transactivates the cardiac muscle-specific
troponin C promoter-enhancer in nonmuscle cells. Mol Cell Biol.
14:7517–7526. 1994.PubMed/NCBI
|
|
25
|
Zhao R, Watt AJ, Battle MA, Li J, Bondow
BJ and Duncan SA: Loss of both GATA4 and GATA6 blocks cardiac
myocyte differentiation and results in acardia in mice. Dev Biol.
317:614–619. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Jay PY, Harris BS, Maguire CT, Buerger A,
Wakimoto H, Tanaka M, Kupershmidt S, Roden DM, Schultheiss TM,
O’Brien TX, Gourdie RG, Berul CI and Izumo S: Nkx2-5 mutation
causes anatomic hypoplasia of the cardiac conduction system. J Clin
Invest. 113:1130–1137. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Terada R, Warren S, Lu JT, Chien KR,
Wessels A and Kasahara H: Ablation of Nkx2-5 at mid-embryonic stage
results in premature lethality and cardiac malformation. Cardiovasc
Res. 91:289–299. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Takeda M, Briggs LE, Wakimoto H, Marks MH,
Warren SA, Lu JT, Weinberg EO, Robertson KD, Chien KR and Kasahara
H: Slow progressive conduction and contraction defects in loss of
Nkx2-5 mice after cardiomyocyte terminal differentiation. Lab
Invest. 89:983–993. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Schlesinger J, Schueler M, Grunert M,
Fischer JJ, Zhang Q, Krueger T, Lange M, Tönjes M, Dunkel I and
Sperling SR: The cardiac transcription network modulated by Gata4,
Mef2a, Nkx2.5, Srf, histone modifications, and microRNAs. PLoS
Genet. 7. pp. e10013132011, View Article : Google Scholar
|
|
30
|
Yamagishi H, Yamagishi C, Nakagawa O,
Harvey RP, Olson EN and Srivastava D: The combinatorial activities
of Nkx2.5 and dHAND are essential for cardiac ventricle formation.
Dev Biol. 239:190–203. 2001. View Article : Google Scholar
|
|
31
|
Bruneau BG, Nemer G, Schmitt JP, Charron
F, Robitaille L, Caron S, Conner DA, Gessler M, Nemer M, Seidman CE
and Seidman JG: A murine model of Holt-Oram syndrome defines roles
of the T-box transcription factor Tbx5 in cardiogenesis and
disease. Cell. 106:709–721. 2001. View Article : Google Scholar : PubMed/NCBI
|
